PC
ARNA

PA Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PA Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,800
Closed -$400K – 188
2019
Q4 		$400K Buy
+8,800
New +$416K 0.35% 93

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

PA Capital's ARNA Position: Q3 2020 in Review

PA Capital reduced its Arena Pharmaceuticals Inc (ARNA) stake by 22% in Q3 2020, selling an estimated $217K and leaving 11,606 shares worth $868K. The position accounts for 0.61% of the portfolio, ranked #54.

PA Capital first reported a position in ARNA in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.29M in Q1 2020. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • PA Capital held 11,606 shares of Arena Pharmaceuticals Inc worth $868K as of Q3 2020.
  • PA Capital sold 3,250 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $217K.
  • Arena Pharmaceuticals Inc made up 0.61% of PA Capital's portfolio in Q3 2020, its #54 holding.
  • PA Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and has held it in 8 quarters since.
  • PA Capital's Arena Pharmaceuticals Inc position peaked at $1.29M in Q1 2020.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.